Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ASD141 for safety, tolerability, pharmacokinetics, and preliminary efficacy in metastatic solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ASD141

Snippet

Sponsor: Ascendo Biotechnology Co., Ltd. | Conditions: Metastatic Solid Tumor | Phase 1 | Status: RECRUITING